Oncotect Inc.

RALEIGH, NC · Founded 2023 · Medtech · Private

At-home cancer screening test kit for dogs

Claim this profile

Follows are private to you and power your alerts

Updated · oncotect.co

Sector
Medtech
Headquarters
RALEIGH, NC
Founded
2023
Latest Form D
$125K, Aug 2024
Total capital
$125K
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$125K
1 Form D · last Aug 2024
26 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
2 pending

Capital timeline

2024FEDERAL ↑EQUITY ↓Cumulative $125K1st Form D$125K
2024FEDERAL ↑EQUITY ↓Cumulative $125K1st Form D$125K

Latest events

  • Private capital raisedForm D · SEC · 1st filing$125K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Chan NamgongExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 2
  • PendingCancer Screening In Companion AnimalsUSPTOApplication 18585626
  • PendingCancer Screening In Companion AnimalsUSPTOApplication PCTUS2022041330

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .